| AfterQC: automatic filtering, trimming, error removing and quality control for fastq data S Chen, T Huang, Y Zhou, Y Han, M Xu, J Gu BMC bioinformatics 18, 91-100, 2017 | 311 | 2017 |
| Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade YL Xiaoliang Liu, Jianfei Yao, Lele Song, Sujing Zhang, Tanxiao Huang Journal for ImmunoTherapy of Cancer 7 (204), 2019 | 68 | 2019 |
| Gencore: an efficient tool to generate consensus reads for error suppressing and duplicate removing of NGS data JG Shifu Chen, Yanqing Zhou, Yaru Chen, Tanxiao Huang, Wenting Liao, Yun Xu ... BMC Bioinformatics, https://bmcbioinformatics.biomedcentral., 2019 | 53 | 2019 |
| Comprehensive analysis of POLE and POLD1 Gene Variations identifies cancer patients potentially benefit from immunotherapy in Chinese population J Yao, Y Gong, W Zhao, Z Han, S Guo, H Liu, X Peng, W Xiao, Y Li, ... Scientific Reports 9 (1), 15767, 2019 | 46 | 2019 |
| GeneFuse: detection and visualization of target gene fusions from DNA sequencing data S Chen, M Liu, T Huang, W Liao, M Xu, J Gu International journal of biological sciences 14 (8), 843, 2018 | 40 | 2018 |
| Detection of urothelial bladder carcinoma via microfluidic immunoassay and single-cell DNA copy-number alteration analysis of captured urinary-exfoliated tumor cells A Chen, G Fu, Z Xu, Y Sun, X Chen, KS Cheng, KH Neoh, Z Tang, S Chen, ... Cancer Research 78 (14), 4073-4085, 2018 | 39 | 2018 |
| Monitoring colorectal cancer following surgery using plasma circulating tumor DNA X Sun, T Huang, F Cheng, K Huang, M Liu, W He, M Li, X Zhang, M Xu, ... Oncology Letters, 2018 | 38 | 2018 |
| The contribution of hereditary cancer-related germline mutations to lung cancer susceptibility M Liu, X Liu, P Suo, Y Gong, B Qu, X Peng, W Xiao, Y Li, Y Chen, Z Zeng, ... Translational Lung Cancer Research 9 (3), 646, 2020 | 36 | 2020 |
| Circulating tumor DNA is capable of monitoring the therapeutic response and resistance in advanced colorectal cancer patients undergoing combined target and chemotherapy H Cao, X Liu, Y Chen, P Yang, T Huang, L Song, R Xu Frontiers in oncology 10, 466, 2020 | 30 | 2020 |
| The genomic characteristics of ALK fusion positive tumors in Chinese NSCLC patients S Liu, T Huang, M Liu, W He, YS Zhao, L Yang, Y Long, D Zong, H Zeng, ... Frontiers in Oncology 10, 726, 2020 | 25 | 2020 |
| MutScan: fast detection and visualization of target mutations by scanning FASTQ data S Chen, T Huang, T Wen, H Li, M Xu, J Gu BMC bioinformatics 19, 1-11, 2018 | 16 | 2018 |
| Targeted deep sequencing helps distinguish independent primary tumors from intrapulmonary metastasis for lung cancer diagnosis J Liu, G Mao, Y Li, L Tao, W Wang, X Peng, J Wang, X Li, X Luan, R Luo, ... Journal of Cancer Research and Clinical Oncology 146, 2359-2367, 2020 | 12 | 2020 |
| Sequencing of circulating tumor DNA for dynamic monitoring of gene mutations in advanced non-small cell lung cancer R Xu, G Zhong, T Huang, W He, C Kong, X Zhang, Y Wang, M Liu, M Xu, ... Oncology Letters 15 (2018), 3726-3734, 2018 | 9 | 2018 |
| Metastatic Low‐Grade Sarcoma with CARS‐ALK Fusion Dramatically Responded to Multiple ALK Tyrosine Kinase Inhibitors: A Case Report with Comprehensive … XD Jiao, K Liu, M Xu, G Yu, D Liu, T Huang, BD Qin, M Liu, Y Wu, Y Ling, ... The Oncologist 26 (4), e524-e529, 2021 | 7 | 2021 |
| The genomic characteristics of RET fusion positive tumors in Chinese non-small cell lung cancer (NSCLC) patients G Wu, L Guo, Y Gu, T Huang, M Liu, X Zou, B Yang, P Huang, C Wen, L Yi, ... Journal of Cancer Research and Clinical Oncology 149 (3), 1019-1028, 2023 | 5 | 2023 |
| Prognostic factors of colorectal cancer: a comparative study on patients with or without liver metastasis H Peng, G Liu, Y Bao, X Zhang, L Zhou, C Huang, Z Song, S Cao, S Dang, ... Frontiers in Oncology 11, 626190, 2021 | 5 | 2021 |
| The prognostic value of HRD mutations in liver cancer. J Chen, T Huang, M Liu, W Liao, M Fu, B Yang, J Duan, S Chen, Y Guo Journal of Clinical Oncology 38 (15_suppl), e13546-e13546, 2020 | 5 | 2020 |
| Circulating tumor DNA sequencing for colorectal cancers: a comparative analysis of colon cancer and rectal cancer data K Huang, H Qu, X Zhang, T Huang, X Sun, W He, M Li, L Lin, M Xu, ... Cancer Biomarkers 26 (3), 313-322, 2019 | 5 | 2019 |
| Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population J Yao, Y Zhen, J Fan, Y Gong, Y Ye, S Guo, H Liu, X Li, G Li, P Yang, ... Cancer Biology & Medicine 19 (5), 707, 2022 | 4 | 2022 |
| Dynamic monitoring of driver gene mutation profiles in plasma cfDNA using an 85 gene panel for postoperative prognosis in colorectal cancer. T Huang, L Xia, M Xu, Y Liu, X Zhang, CE Melancon, M Liu, J Edwards, ... Journal of Clinical Oncology 36 (15_suppl), e15536-e15536, 2018 | 4 | 2018 |
Shifu ChenHaploX BiotechnologyVerified email at haplox.com
